Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Long-term outcomes and second cancers data
Dr Lunning discusses emerging long-term data, European registry size, and implications for expanding cellular therapy use.
Play episode from 03:55
Transcript
